MnO2-Based Nanoplatform Serves as Drug Vehicle and MRI Contrast Agent for Cancer Theranostics.
Zhang M, Xing L, Ke H, He YJ, Cui PF, Zhu Y, Jiang G, Qiao JB, Lu N, Chen H, Jiang HL.
Zhang M, et al. Among authors: jiang hl, jiang g.
ACS Appl Mater Interfaces. 2017 Apr 5;9(13):11337-11344. doi: 10.1021/acsami.6b15247. Epub 2017 Mar 21.
ACS Appl Mater Interfaces. 2017.
PMID: 28291320